|
[1]
|
The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis
|
|
2021 |
|
|
|
|
[2]
|
FREQUENCY OF TET2 GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
|
|
2021 |
|
|
|
|
[3]
|
JAK2 and TET2 Mutation in Polycythemia Vera
|
|
Cureus,
2021 |
|
|
|
|
[4]
|
TET2, DNMT3A, IDH1, and JAK2 mutation in myeloproliferative neoplasms in southern Iran
|
|
… Journal of Organ …,
2021 |
|
|
|
|
[5]
|
FREQUENCY OF TET2 GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS.
|
|
Pakistan Armed …,
2021 |
|
|
|
|
[6]
|
Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000–2018
|
|
BMC cancer,
2019 |
|
|
|
|
[7]
|
Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR …
|
|
2019 |
|
|
|
|
[8]
|
Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology
|
|
Critical Reviews in Oncology/Hematology,
2018 |
|
|
|
|
[9]
|
Значение клинических и молекулярно-генетических факторов в стратификации рисков у больных истинной полицитемией
|
|
2017 |
|
|
|
|
[10]
|
Pro-and Antifibrotic Factors in the Serum of Patients with Chronic Myeloproliferative Disorders
|
|
Clinical oncohematology,
2017 |
|
|
|
|
[11]
|
Genomic profile of a patient with triple negative essential thrombocythemia, unresponsive to therapy: A case report and literature review
|
|
Journal of Advanced Research,
2017 |
|
|
|
|
[12]
|
TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
|
|
Turkish Journal of Hematology,
2017 |
|
|
|
|
[13]
|
MİYELOPROLİFERATİF NEOPLAZMLARA MOLEKÜLER GENETİK YAKLAŞIM.
|
|
Nobel Medicus Journal,
2017 |
|
|
|
|
[14]
|
БИОЛОГИЯ МИЕЛОПРОЛИФЕРАТИВНЫХ НОВООБРАЗОВАНИЙ
|
|
2016 |
|
|
|
|
[15]
|
Biology of Myeloproliferative Malignancies
|
|
Clinical oncohematology,
2016 |
|
|
|
|
[16]
|
Myeloproliferative neoplasms: Current molecular biology and genetics
|
|
Critical reviews in oncology/hematology,
2015 |
|
|
|
|
[17]
|
Myeloproliferative Neoplasms Associated with Mutation in JAK2V617F and Tyrosine Kinase Inhibitors as Therapeutic Strate
|
|
Research in Molecular Medicine,
2015 |
|
|
|
|
[18]
|
Myeloproliferative disorders and its associated mutations
|
|
Research in Molecular Medicine,
2014 |
|
|
|
|
[19]
|
The relationship between Human Papillomavirus and Epstein-Barr virus infections with breast cancer of Iranian patients
|
|
2013 |
|
|
|
|
[20]
|
genes JAK2
|
|
|
|
|
|
|
[21]
|
polycythemia vera
|
|
|
|
|
|
|
[22]
|
essential thrombocythemia
|
|
|
|
|
|
|
[23]
|
ЗНАЧЕНИЕ КЛИНИЧЕСКИХ И МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКИХ ФАКТОРОВ В СТРАТИФИКАЦИИ РИСКОВ У БОЛЬНЫХ ИСТИННОЙ …
|
|
ИС Мартынкевич
|
|
|
|